Clinical trial
Fluoxetine to Reduce Cocaine Use in Cocaine and Opioid Addicts
NCT00142779 · National Institute on Drug Abuse (NIDA), NIH · Completed
Key facts
| NCT number | NCT00142779 |
|---|---|
| Title | Fluoxetine to Reduce Cocaine Use in Cocaine and Opioid Addicts |
| Official title | Serotonin Treatment of Cocaine Dependence |
| Lead sponsor | National Institute on Drug Abuse (NIDA), NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Cocaine-Related Disorders, Opioid-Related Disorders |
| Intervention type | Drug |
| Interventions | Fluoxetine |
| Enrollment | 220 |
| Start date | Apr 1, 2001 |
| Primary completion | Jan 1, 2006 |
| Completion | Mar 1, 2006 |
| First posted | Sep 2, 2005 |
| Last update posted | Jan 12, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: